We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current AGEN market cap is 2.42B. The company's latest EPS is USD -0.5872 and P/E is -9.83.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.77M | 29.2M | 22.9M | 25.3M | 24.32M |
| Operating Income | -41.65M | -56.81M | -54.75M | -54.66M | -46.34M |
| Net Income | -54.28M | -71.15M | -68.31M | -69.07M | -62.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 150.05M | 88.17M | 295.67M | 98.84M | 156.87M |
| Operating Income | -70.14M | -117.24M | 25.75M | -179.43M | -159.55M |
| Net Income | -107.87M | -181.12M | -24.14M | -220.29M | -245.97M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 429.02M | 413.56M | 412.85M | 383.59M | 335.47M |
| Total Liabilities | 440.86M | 468.46M | 465.96M | 460.35M | 450.76M |
| Total Equity | -11.84M | -54.9M | -53.11M | -76.76M | -115.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 155.34M | 214.51M | 465.96M | 413.56M | 313.91M |
| Total Liabilities | 359.76M | 399.1M | 418.05M | 468.46M | 462.3M |
| Total Equity | -231.34M | -211.5M | 47.91M | -54.9M | -148.38M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -128.04M | -175.37M | -58.53M | -118.57M | -180.37M |
| Investing | -27.23M | -33.61M | -11.49M | -10.97M | 576k |
| Financing | 72.06M | 95.83M | 56.25M | 94.51M | 129.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.68M | -139.1M | 10.15M | -175.37M | -224.2M |
| Investing | -4.66M | -4.44M | -43.15M | -33.61M | 3.4M |
| Financing | 31.32M | 183.86M | 225.26M | 95.83M | 119.87M |
| Market Cap | 2.42B |
| Price to Earnings Ratio | -9.83 |
| Price to Sales Ratio | 15.41 |
| Price to Cash Ratio | 31.76 |
| Price to Book Ratio | -16.29 |
| Dividend Yield | - |
| Shares Outstanding | 418.92M |
| Average Volume (1 week) | 1.38M |
| Average Volume (1 Month) | 6.86M |
| 52 Week Change | -83.97% |
| 52 Week High | 42.60 |
| 52 Week Low | 4.775 |
| Spread (Intraday) | 1.18 (17.51%) |
| Company Name | Agenus Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.agenusbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
